within Pharmacolibrary.Drugs.ATC.A;

model A07XA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 8.333333333333334e-08,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07XA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Calcium compounds are a class of drugs and supplements used primarily for the treatment and prevention of calcium deficiency, including conditions such as osteoporosis, hypocalcemia, and as phosphate binders in chronic kidney disease. They may also be used as antacids for gastrointestinal disorders. These compounds are generally considered safe and are widely approved and used worldwide.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration of calcium compounds (e.g., calcium carbonate) in healthy adult individuals; specific peer-reviewed publications reporting detailed PK profiles for ATC A07XA03 are lacking.</p><h4>References</h4><ol><li><p>Buzalaf, MAR, et al., &amp; Ten Cate, JM (2011). Mechanisms of action of fluoride for caries control. <i>Monographs in oral science</i> 22 97–114. DOI:<a href=\"https://doi.org/10.1159/000325151\">10.1159/000325151</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21701194/\">https://pubmed.ncbi.nlm.nih.gov/21701194</a></p></li><li><p>Straub, DA (2007). Calcium supplementation in clinical practice: a review of forms, doses, and indications. <i>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition</i> 22(3) 286–296. DOI:<a href=\"https://doi.org/10.1177/0115426507022003286\">10.1177/0115426507022003286</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17507729/\">https://pubmed.ncbi.nlm.nih.gov/17507729</a></p></li><li><p>Li, Y, et al., &amp; Cui, Y (2023). Effects of calcium supplements on oral bioavailability of fluoride in soil based on In Vivo and In Vitro methods. <i>Journal of hazardous materials</i> 456 131663–None. DOI:<a href=\"https://doi.org/10.1016/j.jhazmat.2023.131663\">10.1016/j.jhazmat.2023.131663</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37224715/\">https://pubmed.ncbi.nlm.nih.gov/37224715</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07XA03;
